首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Expert opinion on drug safety

缩写:EXPERT OPIN DRUG SAF

ISSN:1474-0338

e-ISSN:1744-764X

IF/分区:3.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引2839
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Milind Y Desai,Veronique Michaud,David Thacker et al. Milind Y Desai et al.
Introduction: Several sarcomeric gene abnormalities associated with left ventricular thickening, hypercontractility, and high left ventricular ejection fraction define hypertrophic cardiomyopathy (HCM). Standard treatment...
Luran Xiong,Kunjie Li,Xinyi Feng et al. Luran Xiong et al.
Background and aims: Ciprofol (HSK3486), a novel intravenous anesthetic with a chemical structure similar to propofol, is not inferior to propofol in terms of its effectiveness. We compared the effects of ciprofol and pro...
Krzysztof Irlik,Hanna Kwiendacz,Wiktoria Ignacy et al. Krzysztof Irlik et al.
Introduction: Advanced chronic kidney disease (CKD), defined as an estimated glomerular filtration rate < 30 ml/min/1.73 m2, significantly amplifies the challenges of managing atrial fibrillation (AF), highly prevalent in...
Amanda DeLuca,Ashley Schultz,Hannah Ofori et al. Amanda DeLuca et al.
Introduction: Insulin remains the mainstay of diabetes management. Once weekly insulins (OWI) being investigated as viable options for both type 1 and type 2 diabetes. Less frequent dosing and better pharmacokinetic profi...
Bo Xu,Tianqiao Zhang,Yechuan He et al. Bo Xu et al.
Background: There is conflicting real-world evidence regarding the risk of breast and bladder cancer associated with sodium glucose cotransporter 2 (SGLT2) inhibitors. We conducted a pharmacovigilance study on SGLT2 inhib...
Da Li,Yunfeng Li,Lei Yao et al. Da Li et al.
Background: This study conducts a comprehensive comparative analysis of adverse event (AE) signals between sacubitril/valsartan and valsartan, two pivotal cardiovascular drugs for heart failure and hypertension, utilizing...